These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 16264208)
1. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts. Blackman DJ; Choudhury RP; Banning AP; Channon KM J Invasive Cardiol; 2005 Nov; 17(11):609-12. PubMed ID: 16264208 [TBL] [Abstract][Full Text] [Related]
2. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: the Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Stankovic G; Colombo A; Presbitero P; van den Branden F; Inglese L; Cernigliaro C; Niccoli L; Bartorelli AL; Rubartelli P; Reifart N; Heyndrickx GR; Saunamäki K; Morice MC; Sgura FA; Di Mario C; Circulation; 2003 Jul; 108(1):37-42. PubMed ID: 12821546 [TBL] [Abstract][Full Text] [Related]
3. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Popma JJ; Cox N; Hauptmann KE; Reifart N; Virmani R; Emira K; Murphy S; Gibson CM; Grube E Catheter Cardiovasc Interv; 2002 Oct; 57(2):125-34. PubMed ID: 12357506 [TBL] [Abstract][Full Text] [Related]
4. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Baim DS; Wahr D; George B; Leon MB; Greenberg J; Cutlip DE; Kaya U; Popma JJ; Ho KK; Kuntz RE; Circulation; 2002 Mar; 105(11):1285-90. PubMed ID: 11901037 [TBL] [Abstract][Full Text] [Related]
5. Distal embolization during native vessel and vein graft coronary intervention with a vascular protection device: predictors of high-risk lesions. El-Jack SS; Suwatchai P; Stewart JT; Ruygrok PN; Ormiston JA; West T; Webster MW J Interv Cardiol; 2007 Dec; 20(6):474-80. PubMed ID: 18042052 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up after percutaneous coronary intervention with polytetrafluoroethylene-covered Symbiot stents compared to bare metal stents, with and without FilterWire embolic protection, in diseased saphenous vein grafts. Bennett J; Dens J; Stammen F; Coussement P; Janssens L; Claeys M; Vrolix M; Sinnaeve P; Dubois C; Desmet W Acta Cardiol; 2013 Feb; 68(1):1-9. PubMed ID: 23457903 [TBL] [Abstract][Full Text] [Related]
7. Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trial. Turco MA; Buchbinder M; Popma JJ; Weissman NJ; Mann T; Doucet S; Johnson WL; Greenberg JD; Leadley K; Russell ME Catheter Cardiovasc Interv; 2006 Sep; 68(3):379-88. PubMed ID: 16892434 [TBL] [Abstract][Full Text] [Related]
9. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. Mauri L; Cox D; Hermiller J; Massaro J; Wahr J; Tay SW; Jonas M; Popma JJ; Pavliska J; Wahr D; Rogers C J Am Coll Cardiol; 2007 Oct; 50(15):1442-9. PubMed ID: 17919563 [TBL] [Abstract][Full Text] [Related]
10. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Stone GW; Rogers C; Hermiller J; Feldman R; Hall P; Haber R; Masud A; Cambier P; Caputo RP; Turco M; Kovach R; Brodie B; Herrmann HC; Kuntz RE; Popma JJ; Ramee S; Cox DA; Circulation; 2003 Aug; 108(5):548-53. PubMed ID: 12874191 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. Cohen DJ; Murphy SA; Baim DS; Lavelle TA; Berezin RH; Cutlip DE; Ho KK; Kuntz RE; J Am Coll Cardiol; 2004 Nov; 44(9):1801-8. PubMed ID: 15519010 [TBL] [Abstract][Full Text] [Related]
12. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. Kereiakes DJ; Turco MA; Breall J; Farhat NZ; Feldman RL; McLaurin B; Popma JJ; Mauri L; Zimetbaum P; Massaro J; Cutlip DE; JACC Cardiovasc Interv; 2008 Jun; 1(3):248-57. PubMed ID: 19463308 [TBL] [Abstract][Full Text] [Related]
13. Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Mehta SK; Frutkin AD; Milford-Beland S; Klein LW; Shaw RE; Weintraub WS; Krone RJ; Anderson HV; Kutcher MA; Marso SP; Am J Cardiol; 2007 Oct; 100(7):1114-8. PubMed ID: 17884373 [TBL] [Abstract][Full Text] [Related]
14. "Over-and-under" pericardial covered stent with paclitaxel balloon in a saphenous vein graft. Wykrzykowska JJ; Gutiérrez-Chico JL; van Geuns RJ Catheter Cardiovasc Interv; 2010 May; 75(6):964-6. PubMed ID: 20432403 [TBL] [Abstract][Full Text] [Related]
15. Clinical and economic outcomes of embolic complications and strategies for distal embolic protection during percutaneous coronary intervention in saphenous vein grafts. Senter SR; Nathan S; Gupta A; Klein LW J Invasive Cardiol; 2006 Feb; 18(2):49-53. PubMed ID: 16446515 [TBL] [Abstract][Full Text] [Related]
18. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial. Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178 [TBL] [Abstract][Full Text] [Related]
19. 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial. Stone GW; Goldberg S; O'Shaughnessy C; Midei M; Siegel RM; Cristea E; Dangas G; Lansky AJ; Mehran R JACC Cardiovasc Interv; 2011 Mar; 4(3):300-9. PubMed ID: 21435608 [TBL] [Abstract][Full Text] [Related]
20. Clinical experiences using the FilterWire EX for distal embolic protection during complex percutaneous coronary interventions. Lev E; Teplitsky I; Fuchs S; Shor N; Assali A; Kornowski R Int J Cardiovasc Intervent; 2004; 6(1):28-32. PubMed ID: 15204170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]